Facultad de Medicina (FM)
Centro académico
Icahn School of Medicine at Mount Sinai
Nueva York, Estados UnidosIcahn School of Medicine at Mount Sinai-ko ikertzaileekin lankidetzan egindako argitalpenak (128)
2024
-
A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey
European Journal of Surgical Oncology, Vol. 50, Núm. 10
-
Correction to: GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review (Blood Cancer Journal, (2024), 14, 1, (24), 10.1038/s41408-023-00966-9)
Blood Cancer Journal
-
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review
Blood Cancer Journal, Vol. 14, Núm. 1
-
Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP
Archivos de Bronconeumologia, Vol. 60, Núm. 9, pp. 559-564
-
Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience
Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100
-
Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a–b; ≤20 mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery
Journal of Thoracic Oncology, Vol. 19, Núm. 3, pp. 476-490
-
SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer
Cell Reports, Vol. 43, Núm. 3
-
Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study
Nature Medicine, Vol. 30, Núm. 7, pp. 2020-2029
-
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease
Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 4
-
Targeting metalloproteases is a promising strategy to enhance immunotherapy responses by overcoming immune exclusion in hepatocellular carcinoma
Gut
-
The tip of the iceberg: a plethora of lung nodules in the general population
The European respiratory journal
2023
-
A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP)
Radiology, Vol. 309, Núm. 2, pp. e231988
-
Biallelic TET2 mutations confer sensitivity to 5′-azacitidine in acute myeloid leukemia
JCI Insight, Vol. 8, Núm. 2
-
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS
Blood cancer journal
-
Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwide
The Lancet Oncology, Vol. 24, Núm. 12, pp. e472-e518
-
Plain language summary of the MonumenTAL-1 study of talquetamab in people with relapsed or refractory multiple myeloma
Future Oncology, Vol. 19, Núm. 27, pp. 1823-1840
-
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
ESMO Open, Vol. 8, Núm. 3
2022
-
Activation of the unfolded protein response (Upr) is associated with cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of fibropolycystic liver disease
Cancers, Vol. 14, Núm. 1
-
Cancer vaccines: the next immunotherapy frontier
Nature Cancer, Vol. 3, Núm. 8, pp. 911-926
-
Clinical and technical outcomes of patients undergoing endoscopic ultrasound-guided gastroenterostomy using 20-mm vs15-mm lumen-apposing metal stents
Endoscopy, Vol. 54, Núm. 7, pp. 680-687